Table 1.
Clinical, psychological, psychophysical, health-related, and cognitive data of the sample (n = 113).
| Mean | SD | Min. | Max. | |
|---|---|---|---|---|
| Age (years) | 52.8 | 10.8 | 47.0 | 60.0 |
| Height (cm) | 160.25 | 36.4 | 156.0 | 169.0 |
| Weight (kg) | 72.45 | 16.8 | 57.0 | 110.0 |
| Years with diagnosis | 10.25 | 8.45 | 2.0 | 25.0 |
| Mean-worst pain (NPRS, 0–10) | 6.8 | 1.54 | 1.0 | 10.0 |
| Pain with activity (NPRS, 0–10) | 8.05 | 1.9 | 2.0 | 10.0 |
| HADS-A (0–21) | 11.5 | 3.8 | 1.0 | 20.0 |
| HADS-D (0–21) | 9.9 | 4.0 | 1.0 | 18.0 |
| Sleep (PSQI, 0–21) | 13.7 | 4.0 | 4.0 | 21.0 |
| PPT upper trapezius (kPa) | 134.7 | 56.2 | 50.45 | 273.8 |
| PPT mastoid (kPa) | 163.15 | 88.6 | 21.3 | 316.8 |
| PPT elbow (kPa) | 157.0 | 84.75 | 28.3 | 309.0 |
| PPT second metacarpal (kPa) | 126.7 | 56.55 | 15.5 | 294.0 |
| PPT PSIC (kPa) | 245.0 | 129.3 | 46.65 | 383.6 |
| PPT trochanter (kPa) | 271.1 | 119.4 | 74.5 | 421.8 |
| PPT knee (kPa) | 157.75 | 105.05 | 16.45 | 263.5 |
| PPT tibialis anterior (kPa) | 199.4 | 104.85 | 23.15 | 245.8 |
| FIQ (0–100) | 64.3 | 12.85 | 18.2 | 102.6 |
| CSI Score (0–100) | 70.25 | 11.95 | 36.0 | 99.0 |
| Catastrophizing (PCS, 0–52) | 22.6 | 12.35 | 0.0 | 47.0 |
| Function (FHAQ, 0–3) | 1.25 | 0.55 | 0.0 | 2.6 |
| Hypervigilance (PVQ, 0–45) | 27.25 | 8.1 | 8.0 | 47.0 |
| Kinesiophobia (TSK-11) | 25.0 | 7.55 | 11.0 | 43.0 |
| Pain detect (0–38) | 19.7 | 6.9 | 0.0 | 32.0 |
| Quality of life (EQ-5DL, 0–1) | 0.4 | 0.25 | 0.1 | 0.9 |
| S-LANSS (0–24) | 17.65 | 5.25 | 5.0 | 28.0 |
| Test up and go (TUG, seg.) | 12.35 | 4.7 | 4.45 | 29.7 |
NPRS: Numerical Pain Rate Scale; PPT: Pressure Pain Thresholds; S-LANSS: Self-reported version of the Leeds Assessment of Neuropathic Symptoms and Signs; CSI: Central Sensitization Inventory; HADS: Hospital Anxiety and Depression Scale (A: Anxiety, D: Depression); FIQ: Fibromyalgia Impact Questionnaire; FHAQ: Fibromyalgia Health Assessment Questionnaire; PCS: Pain Catastrophizing Scale; PVAQ: Pain Vigilance and Awareness Questionnaire.